Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Recruiting
Loxo Oncology, Inc.
Phase 3
737
California, Florida, Louisiana, Maryland, Montana, Pennsylvania, South Carolina, Tennessee
2022-07-22
Active, closed
Hoffmann-La Roche
Phase 3
922
Arizona, California, Florida, Maryland, Tennessee, Texas, Washington
2022-07-18
Active, closed
Alexion Pharmaceuticals, Inc.
Observational
4
Georgia, Pennsylvania, Tennessee, Washington
2022-07-15
Recruiting
Akouos, Inc.
Observational
150
Iowa, Ohio, Pennsylvania, Tennessee
2022-07-14
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,546
California, Florida, Ohio, Tennessee
2022-07-14
Active, closed
Pfizer
Phase 2
108
Arizona, Florida, Tennessee, Texas
2022-07-11
Recruiting
Amneal Pharmaceuticals, LLC
Phase 3
168
California, Florida, Georgia, Tennessee, Texas, Wyoming
2022-06-29
Recruiting
AC Immune SA
Phase 1/2
304
Arizona, Florida, Indiana, Kansas, Massachusetts, Missouri, North Carolina, Tennessee
2022-06-21
Active, closed
Delcath Systems Inc.
Phase 3
30
California, Florida, North Carolina, Ohio, Tennessee
2022-06-10
Active, closed
Janssen Research & Development, LLC
Phase 1
74
Colorado, New York, North Carolina, Tennessee
2022-05-25
By invitation
NuVasive
Observational
150
California, Connecticut, Maryland, New York, Pennsylvania, Tennessee, Texas
2022-05-10
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
16
Tennessee
2022-05-03
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
13
North Carolina, Pennsylvania, Tennessee
2022-05-02
Active, closed
Editas Medicine, Inc.
Phase 1/2
9
California, Minnesota, New York, Ohio, Pennsylvania, Tennessee
2022-04-29
Active, closed
Sedana Medical
Phase 3
312
Tennessee
2022-04-22
By invitation
AstraZeneca
Phase 3
214
California, Colorado, Tennessee
2022-04-19
Recruiting
CereGate Inc.
Not applicable
41
California, Colorado, Florida, Illinois, North Carolina, Tennessee, Washington
2022-04-18
Recruiting
Aulos Bioscience, Inc.
Phase 1/2
159
Florida, Michigan, Minnesota, Missouri, North Carolina, Tennessee, Texas, Utah
2022-04-04
Active, closed
AstraZeneca
Phase 3
760
Alabama, Arizona, California, Georgia, Maryland, New Mexico, New York, Tennessee
2022-03-28
Active, closed
McGuire Institute
Not applicable
100
Colorado, Illinois, Nebraska, Tennessee, Texas, Washington, Wisconsin
2022-03-22
Recruiting
Trisol Medical
Not applicable
30
California, Georgia, New York, Ohio, Pennsylvania, Tennessee, Virginia
2022-03-02
Active, closed
UroGen Pharma Ltd.
Phase 3
240
Arizona, California, Kansas, Maryland, Missouri, New Jersey, New York, Tennessee
2022-03-01
Active, closed
Katmai Pharmaceuticals Inc.
Phase 1
52
California, Florida, Massachusetts, Michigan, New York, Ohio, Tennessee, Utah
2022-02-25
Active, closed
Stryker Orthopaedics
Not applicable
313
Arizona, California, Illinois, Nevada, New York, North Carolina, Pennsylvania, Tennessee
2022-02-07
Active, closed
Curevo Inc
Phase 2
1,516
Arizona, Florida, Illinois, Kansas, Kentucky, Nevada, Oklahoma, Tennessee
2022-02-02
Active, closed
Ultragenyx Pharmaceutical Inc
Observational
23
Connecticut, Indiana, Maryland, Tennessee, Virginia
2022-01-31
Active, closed
ALX Oncology Inc.
Phase 2/3
127
California, Tennessee, Virginia, Washington
2022-01-15
Active, closed
23andMe, Inc.
Phase 1/2
141
California, Georgia, Michigan, New York, Oregon, Tennessee, Texas, Virginia
2021-12-29
Active, closed
Smith & Nephew, Inc.
Observational
299
Georgia, Massachusetts, Michigan, New York, North Carolina, Oregon, South Carolina, Tennessee
2021-12-21
Active, closed
Eli Lilly and Company
Phase 3
152
California, Florida, Massachusetts, Minnesota, New York, Pennsylvania, Tennessee, Texas
2021-12-20
By invitation
QED Therapeutics, a BridgeBio company
Phase 2
300
California, Colorado, Delaware, Maryland, Missouri, Ohio, Tennessee, Wisconsin
2021-12-06
Active, closed
Sanofi
Phase 2
109
Alabama, Arizona, California, Florida, New Mexico, New York, Oklahoma, Tennessee
2021-11-10
Active, closed
Venus Concept
Not applicable
36
California, New Jersey, Tennessee
2021-11-01
Active, closed
Koning Corporation
Not applicable
1,024
Florida, Georgia, Tennessee
2021-10-30
Recruiting
Bayer
Phase 1/2
400
Arizona, California, Georgia, Maryland, Massachusetts, Michigan, New York, Tennessee
2021-10-25
By invitation
ByHeart
Observational
2,000
Alabama, Arizona, Arkansas, Idaho, Ohio, South Carolina, Tennessee, Utah
2021-10-19
Active, closed
Novartis Pharmaceuticals
Phase 3
405
Colorado, Florida, Kentucky, Massachusetts, North Carolina, Oregon, South Dakota, Tennessee
2021-10-06
Active, closed
AstraZeneca
Phase 1/2
136
Georgia, Indiana, New York, Tennessee
2021-09-28
Active, closed
Ultragenyx Pharmaceutical Inc
Phase 1/2
82
California, Illinois, Indiana, Massachusetts, Michigan, North Carolina, Ohio, Tennessee
2021-09-27
Active, closed
Hoffmann-La Roche
Phase 1/2
42
California, Florida, Michigan, Minnesota, New York, Ohio, Tennessee
2021-09-14
Active, closed
Passage Bio, Inc.
Phase 1/2
30
Michigan, Pennsylvania, Tennessee, Texas
2021-09-14
Active, closed
Tessa Therapeutics
Phase 1
21
California, Tennessee, Texas
2021-09-08
Active, closed
Nuvation Bio Inc.
Phase 2
217
California, Florida, Louisiana, Minnesota, New Jersey, Ohio, Tennessee, Texas
2021-09-01
Active, closed
Gilead Sciences
Phase 1
304
California, Connecticut, Massachusetts, Tennessee, Texas, Wisconsin
2021-08-18
Recruiting
Pierre Fabre Medicament
Phase 1
400
California, Colorado, Florida, Minnesota, New Jersey, New York, Ohio, Tennessee
2021-08-04
Active, closed
CardioMech AS
Not applicable
35
California, Illinois, Kansas, Minnesota, New York, North Carolina, Ohio, Tennessee
2021-07-27
Active, closed
SightGlass Vision, Inc.
Not applicable
200
California, Florida, Kansas, Louisiana, Missouri, New York, South Dakota, Tennessee
2021-07-19
Recruiting
I-Mab Biopharma US Limited
Phase 1
330
California, Colorado, Indiana, Massachusetts, New Jersey, New York, North Carolina, Tennessee
2021-06-29
Active, closed
Merck Sharp & Dohme LLC
Phase 2
302
Florida, Georgia, Illinois, New York, Pennsylvania, Tennessee, Texas, Washington
2021-06-25
Recruiting
Hoffmann-La Roche
Phase 1/2
316
California, Massachusetts, New Jersey, North Carolina, Pennsylvania, Tennessee
2021-06-22
Active, closed
Foghorn Therapeutics Inc.
Phase 1
144
California, Massachusetts, New York, Tennessee, Texas
2021-06-14
Active, closed
Sanofi
Observational
16
New York, North Carolina, Ohio, Tennessee, Washington
2021-06-10
Recruiting
Edgewood Oncology Inc.
Phase 1
112
Florida, Ohio, Tennessee, Texas
2021-06-07
Recruiting
Bristol-Myers Squibb
Phase 1/2
1,109
California, Iowa, New Jersey, New York, Oregon, Tennessee, Texas
2021-05-27
Active, closed
Genentech, Inc.
Phase 1
65
California, Colorado, Iowa, Maryland, Missouri, New York, Tennessee
2021-05-13
Recruiting
Nurix Therapeutics, Inc.
Phase 1
248
California, Colorado, Florida, Illinois, Maryland, New York, Ohio, Tennessee
2021-05-05
Active, closed
Merus B.V.
Phase 1/2
194
California, Tennessee, Utah, Virginia
2021-04-28
Active, closed
Valneva Austria GmbH
Phase 3
363
Arizona, Florida, Illinois, Kentucky, Nebraska, Tennessee, Texas, Utah
2021-04-02
Recruiting
C. R. Bard
Not applicable
220
California, Florida, Massachusetts, New York, North Carolina, Ohio, Pennsylvania, Tennessee
2021-03-26
Active, closed
Verici Dx
Observational
550
Illinois, Maryland, Michigan, Nebraska, Ohio, Pennsylvania, Tennessee, Washington
2021-03-21
Active, closed
BioNTech SE
Phase 2
327
California, Indiana, Minnesota, Ohio, Rhode Island, Tennessee, Texas, Virginia
2021-03-08
Recruiting
RasCal Therapeutics, Inc.
Phase 1
134
California, Colorado, Tennessee
2021-03-03
Active, closed
Tessa Therapeutics
Phase 2
97
California, Illinois, Pennsylvania, Tennessee, Texas
2021-02-01
By invitation
Vertex Pharmaceuticals Incorporated
Phase 3
160
California, Illinois, New York, North Carolina, Pennsylvania, Tennessee, Texas
2021-01-20
Active, closed
Pfizer
Phase 3
257
Florida, Kansas, Massachusetts, Ohio, Tennessee
2021-01-15
Active, closed
Renata Medical
Not applicable
42
California, Massachusetts, Ohio, Tennessee, Washington
2021-01-14
Active, closed
Amgen
Phase 1/2
181
California, Illinois, Maryland, Michigan, New York, Pennsylvania, Tennessee, Texas
2021-01-04
Recruiting
Universal Diagnostics
Observational
1,300
California, Florida, Illinois, Louisiana, Massachusetts, New York, Pennsylvania, Tennessee
2020-12-30
Active, closed
AstraZeneca
Phase 1/2
245
Florida, New York, Ohio, Tennessee, Texas, Virginia
2020-12-28
Active, closed
Daiichi Sankyo
Phase 1
179
Arizona, Colorado, Florida, Oklahoma, Tennessee
2020-12-22
Active, closed
Rakuten Medical, Inc.
Phase 1/2
23
Florida, Kentucky, Minnesota, Oregon, Pennsylvania, Tennessee, Texas
2020-12-21
Active, closed
AstraZeneca
Phase 1
138
New York, North Carolina, Tennessee, Texas
2020-12-17
Active, closed
Edwards Lifesciences
Not applicable
25
California, Georgia, Maryland, Michigan, Minnesota, Oregon, Tennessee, Utah
2020-12-16
Recruiting
Taiho Pharmaceutical Co., Ltd.
Phase 1/2
244
California, Massachusetts, Michigan, New York, Tennessee, Texas
2020-12-16
Active, closed
Adverum Biotechnologies, Inc.
Observational
23
California, Colorado, Florida, Nevada, Pennsylvania, Tennessee, Texas
2020-12-14
Active, closed
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 1/2
232
California, Colorado, Massachusetts, Michigan, New York, Ohio, Oregon, Tennessee
2020-12-14
Recruiting
Arthrex, Inc.
Observational
700
California, Illinois, Tennessee, Texas, Virginia
2020-12-01
Active, closed
Eli Lilly and Company
Phase 1
260
California, Florida, Illinois, Massachusetts, New York, North Carolina, Tennessee, Texas
2020-11-19
Active, closed
AstraZeneca
Phase 3
957
California, Florida, Indiana, Kentucky, Massachusetts, New York, Tennessee, Texas
2020-11-17
Recruiting
Pfizer
Phase 2
320
Arizona, California, Connecticut, Florida, Kentucky, Tennessee, Texas, Washington
2020-11-16
Active, closed
Janssen Research & Development, LLC
Phase 1
158
California, Indiana, New York, Oregon, Tennessee
2020-11-10
Recruiting
AVM Biotechnology Inc
Phase 1/2
144
California, Florida, Illinois, Kentucky, Nebraska, Ohio, Tennessee, Texas
2020-11-06
Active, closed
Bio-Path Holdings, Inc.
Phase 1
30
Georgia, New York, Tennessee, Texas
2020-11-05
Active, closed
Hoffmann-La Roche
Phase 1/2
518
California, Colorado, Connecticut, District of Columbia, Kentucky, Oregon, Tennessee, Texas
2020-11-01
Recruiting
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 1
172
Colorado, Massachusetts, Missouri, New York, North Carolina, Rhode Island, Tennessee, Texas
2020-10-26
Recruiting
Abbott Medical Devices
Observational
3,784
Alabama, Arkansas, California, Illinois, Nebraska, Ohio, Tennessee
2020-10-25
Active, closed
GlaxoSmithKline
Phase 3
302
Arizona, Florida, Massachusetts, Missouri, Tennessee
2020-10-01
Active, closed
Pfizer
Phase 2
362
California, Connecticut, Massachusetts, Michigan, Tennessee, Texas
2020-09-23
Active, closed
Nkarta, Inc.
Phase 1
61
Colorado, Florida, Georgia, Illinois, Ohio, Tennessee, Texas
2020-09-21
Recruiting
AtlasMedx, Incorporated
Phase 1/2
122
California, Maryland, Tennessee, Texas
2020-08-12
Active, closed
MedImmune LLC
Phase 1
67
District of Columbia, Florida, Missouri, New York, Ohio, Pennsylvania, Tennessee
2020-08-05
Active, closed
BicycleTx Limited
Phase 1/2
329
Colorado, Florida, New York, Ohio, Pennsylvania, Tennessee, Texas
2020-07-17
Active, closed
Sapience Therapeutics
Phase 1/2
125
California, Colorado, Illinois, Michigan, New York, North Carolina, Tennessee
2020-07-01
Active, closed
Episurf Medical Inc.
Not applicable
13
Arizona, California, Louisiana, New Jersey, New York, Ohio, Tennessee, Texas
2020-06-18
Active, closed
Sanofi
Phase 3
337
California, Colorado, Florida, Massachusetts, North Carolina, Tennessee, Texas
2020-06-16
Active, closed
Myriad Genetic Laboratories, Inc.
Observational
500
Alabama, California, Florida, Illinois, Maryland, Tennessee
2020-04-30
Active, closed
AstraZeneca
Phase 2
240
Alabama, California, Florida, Nebraska, Ohio, Tennessee, Wisconsin
2020-04-22
Active, closed
Eisai Inc.
Phase 1
31
Florida, Massachusetts, Missouri, Nevada, Tennessee
2020-04-01
Active, closed
Janssen Research & Development, LLC
Phase 1
290
California, New York, North Carolina, Pennsylvania, Tennessee, Wisconsin
2020-02-21
Active, closed
Hoffmann-La Roche
Phase 2/3
325
California, Massachusetts, New York, North Carolina, Tennessee, Texas, Washington
2020-01-29
Active, closed
Takeda
Phase 3
354
California, Florida, Illinois, Maryland, Massachusetts, Tennessee, Virginia
2020-01-10
Active, closed
Novo Nordisk A/S
Phase 3
156
California, Georgia, Indiana, Iowa, Michigan, North Carolina, Pennsylvania, Tennessee
2019-11-13
Active, closed
Boehringer Ingelheim
Phase 1
71
Massachusetts, North Carolina, Tennessee, Texas
2019-11-04
Active, closed
Novo Nordisk A/S
Phase 3
134
California, Georgia, Indiana, Missouri, North Carolina, Tennessee, Texas
2019-10-21
Recruiting
Cellectis S.A.
Phase 1/2
52
California, Colorado, Illinois, Massachusetts, New York, Pennsylvania, Tennessee, Texas
2019-10-14
Active, closed
OncoHost Ltd.
Observational
10,000
Alabama, Florida, Illinois, Iowa, New Jersey, New York, Tennessee, Texas
2019-10-01
Active, closed
CARsgen Therapeutics Co., Ltd.
Phase 1/2
105
Arizona, California, Colorado, Florida, Massachusetts, Minnesota, Tennessee, Texas
2019-09-25
Active, closed
MedImmune LLC
Phase 1/2
61
California, Michigan, Nevada, New York, Ohio, Rhode Island, Tennessee, Texas
2019-09-13
Recruiting
Theralase® Technologies Inc.
Phase 2
90
Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, Tennessee, Texas
2019-08-30
Active, closed
USWM CT, LLC
Phase 1
120
Florida, Massachusetts, Missouri, New York, North Carolina, Oklahoma, Tennessee, Texas
2019-08-20
Active, closed
Novartis Pharmaceuticals
Phase 3
254
Georgia, Massachusetts, North Carolina, Tennessee, Texas
2019-07-26
Active, closed
Novartis Pharmaceuticals
Phase 1/2
217
California, Florida, Illinois, Kansas, Massachusetts, Pennsylvania, Tennessee, Texas
2019-06-26
Active, closed
BioMarin Pharmaceutical
Phase 2
73
California, Delaware, Georgia, Illinois, Ohio, Tennessee, Texas, Wisconsin
2019-06-12
By invitation
AbbVie
Phase 2
865
Arizona, California, Maryland, Massachusetts, Nevada, Pennsylvania, Tennessee, Texas
2019-05-31
Recruiting
Helio Genomics
Observational
1,200
California, Minnesota, Tennessee, Texas
2019-05-21
Active, closed
Novartis Pharmaceuticals
Phase 1
98
Massachusetts, Tennessee
2019-05-07
Active, closed
TCR2 Therapeutics
Phase 1/2
57
California, Florida, Illinois, Maryland, New York, North Carolina, Pennsylvania, Tennessee
2019-04-15
Recruiting
CSL Behring
Phase 4
30
Arizona, California, Iowa, Ohio, Pennsylvania, Tennessee, Texas, Virginia
2019-02-28
Active, closed
Conformal Medical, Inc
Not applicable
64
Arkansas, California, New Hampshire, New York, Ohio, Pennsylvania, Tennessee, Texas
2019-02-22
By invitation
Medneon
Observational
10,000
California, Illinois, Michigan, Tennessee, Texas
2019-01-23
Active, closed
AstraZeneca
Phase 1
175
Iowa, Pennsylvania, Tennessee
2018-12-27
Active, closed
AstraZeneca
Phase 2
401
Florida, Missouri, Pennsylvania, Tennessee, Texas
2018-12-21
Recruiting
Cytrellis Biosystems, Inc.
Not applicable
35
California, Colorado, Florida, New York, Tennessee, Texas
2018-11-12
Active, closed
Poseida Therapeutics, Inc.
Phase 1
100
California, Colorado, Illinois, Kansas, Maryland, Michigan, Pennsylvania, Tennessee
2018-10-29
Active, closed
Janssen Research & Development, LLC
Phase 3
84
California, Colorado, Connecticut, Delaware, Georgia, Minnesota, New York, Tennessee
2018-10-29
Active, closed
AstraZeneca
Phase 1
396
Colorado, Florida, Pennsylvania, Tennessee, Utah
2018-10-11
Active, closed
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2
118
California, Florida, Massachusetts, Michigan, Tennessee, Texas, Washington
2018-09-27
Active, closed
Zimmer Biomet
Not applicable
99
Florida, Kentucky, Michigan, New York, Tennessee, Virginia
2018-08-28
Active, closed
Smith & Nephew, Inc.
Observational
126
Minnesota, Nevada, South Carolina, Tennessee
2018-08-26
Active, closed
SightGlass Vision, Inc.
Not applicable
266
California, Florida, Kansas, Louisiana, Missouri, New York, South Dakota, Tennessee
2018-07-16
Active, closed
Genentech, Inc.
Phase 1
123
Connecticut, Michigan, New York, Tennessee, Texas
2018-06-06
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
890
Alabama, Massachusetts, Minnesota, New York, Ohio, Oklahoma, Tennessee, Texas
2018-05-21
Active, closed
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2
50
Maryland, Massachusetts, Michigan, Pennsylvania, Tennessee, Texas, Utah
2018-05-02
Active, closed
MedImmune LLC
Phase 1
400
Michigan, New York, North Carolina, Rhode Island, Tennessee, Virginia
2018-04-24
Active, closed
Fujifilm Pharmaceuticals U.S.A., Inc.
Phase 1
90
Arizona, California, Colorado, Tennessee, Texas, Washington
2018-03-22
Active, closed
AstraZeneca
Phase 2
154
Alabama, Arizona, Florida, Kentucky, New York, Pennsylvania, Tennessee, Washington
2018-03-16
Active, closed
Daiichi Sankyo Co., Ltd.
Phase 1
890
California, District of Columbia, Georgia, Maryland, Massachusetts, New York, Tennessee, Texas
2018-01-31
Active, closed
Janssen Research & Development, LLC
Phase 1
279
Alabama, California, Colorado, New York, Tennessee
2017-12-16
Active, closed
Sanofi
Phase 3
475
Florida, Missouri, Tennessee, Texas
2017-12-07
Active, closed
Genentech, Inc.
Phase 1
181
Colorado, Massachusetts, New York, Tennessee
2017-11-24
Active, closed
Daiichi Sankyo
Phase 1
312
California, Georgia, Massachusetts, Michigan, New York, Ohio, Pennsylvania, Tennessee
2017-10-30
Active, closed
AstraZeneca
Phase 3
60
California, Georgia, Illinois, Iowa, Massachusetts, Missouri, New York, Tennessee
2017-07-25
Active, closed
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Phase 1/2
190
Arizona, California, Colorado, Michigan, Minnesota, North Carolina, Ohio, Tennessee
2017-06-26
Active, closed
AstraZeneca
Phase 3
1,186
Arizona, California, Florida, Kentucky, Missouri, Ohio, Pennsylvania, Tennessee
2017-06-01
Active, closed
USWM CT, LLC
Phase 1
71
Florida, Missouri, New York, North Carolina, Ohio, Pennsylvania, Tennessee, Texas
2017-05-15
Active, closed
Cerus Corporation
Phase 3
692
Arizona, Connecticut, Florida, Georgia, Maryland, Nevada, Tennessee, Texas
2017-05-11
Active, closed
Pfizer
Phase 3
296
Florida, Massachusetts, New York, Tennessee, Washington
2017-04-27
Active, closed
AbbVie
Phase 1
163
California, Illinois, Massachusetts, North Carolina, Tennessee, Texas, Virginia
2017-02-22
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 1/2
120
California, Colorado, Florida, Massachusetts, New York, Oregon, Tennessee
2017-02-16
Active, closed
AstraZeneca
Phase 1
117
California, Connecticut, Florida, New York, Ohio, Tennessee
2016-12-28
Active, closed
Novartis Pharmaceuticals
Phase 2
22
Alabama, Massachusetts, Michigan, New York, Tennessee
2016-12-15
Active, closed
Genentech, Inc.
Phase 1
200
Massachusetts, New York, Tennessee
2016-12-13
Active, closed
Incyte Corporation
Phase 2
10
California, Kentucky, New York, Tennessee, Texas
2016-11-30
Active, closed
Gilead Sciences
Phase 2
150
California, Colorado, Indiana, Maryland, Missouri, New York, Ohio, Tennessee
2016-11
Active, closed
Gilead Sciences
Phase 2/3
177
District of Columbia, Florida, Georgia, Michigan, New York, North Carolina, Pennsylvania, Tennessee
2016-09-21
Active, closed
Eli Lilly and Company
Phase 2
234
Arizona, New Hampshire, Tennessee, Texas, Wisconsin
2016-09-14
Active, closed
DePuy Orthopaedics
Not applicable
540
Colorado, Florida, New Hampshire, New Jersey, New York, North Carolina, Tennessee, Texas
2016-09-01
Active, closed
Eli Lilly and Company
Phase 2
309
Arizona, California, District of Columbia, Florida, Michigan, Missouri, Pennsylvania, Tennessee
2016-05-19
Active, closed
Acerta Pharma BV
Phase 1
72
Kentucky, Michigan, New Jersey, New York, Ohio, Tennessee, Texas, Washington
2016-04-20
Active, closed
Acerta Pharma BV
Phase 2
60
Arizona, California, District of Columbia, Illinois, New York, Ohio, Tennessee, Texas
2016-03-08
Active, closed
Supernus Pharmaceuticals, Inc.
Phase 3
1,400
Arkansas, California, Colorado, Florida, Oklahoma, Tennessee, Texas, Utah
2016-02-02
Active, closed
BioMarin Pharmaceutical
Phase 2
30
California, Illinois, Maryland, Tennessee, Texas
2016-01-26
Active, closed
Bayer
Phase 1/2
154
California, Florida, Massachusetts, New York, Ohio, Pennsylvania, Tennessee, Texas
2015-12-16
Recruiting
Zimmer Biomet
Not applicable
134
Colorado, North Carolina, Pennsylvania, Tennessee
2015-06
Active, closed
Acerta Pharma BV
Phase 2
107
California, Colorado, District of Columbia, Minnesota, New York, Tennessee, Texas, Washington
2014-09-11
Active, closed
Acerta Pharma BV
Phase 1
12
Ohio, Tennessee, Texas
2014-08-18
Active, closed
AstraZeneca
Phase 1
344
Georgia, Massachusetts, New York, Pennsylvania, Tennessee
2014-08-05
Active, closed
Zimmer Biomet
Not applicable
737
Colorado, Illinois, Indiana, North Carolina, Ohio, Pennsylvania, Tennessee, Texas
2014-07
Active, closed
Gilead Sciences
Phase 2/3
133
California, Colorado, District of Columbia, Florida, Tennessee, Texas
2014-01-16
Active, closed
Novartis Pharmaceuticals
Phase 1/2
259
California, Florida, Massachusetts, Tennessee, Texas, Washington
2013-10-22
